Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 8,070.00
+110.00 (1.38%)
Feb 19, 2026, 10:49 AM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 96.41 billion as of February 18, 2026. Its market cap has increased by 3.10% in one year.
Market Cap
96.41B
Enterprise Value
74.72B
Revenue
884.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
8,070.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 96.41B, a decrease of -9.26%. That is a compound annual growth rate of -8.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 96.41B | -16.33% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Therapeutics | 240.96B |
| Genexine | 201.02B |
| MedPacto | 200.85B |
| Macrogen | 195.80B |
| ENCell | 183.11B |
| GeneOne Life Science | 140.58B |
| IMB Dx | 114.53B |
| iNtRON Biotechnology | 112.35B |